dosing etoposide means dose intensity individualized dosing etoposide infusion feasible extent leukopenia function plasma concentration pretreatment WBC WBCp ALB performance status PS bone marrow function transfusion requirements current study patients fixed dose versus target WBC nadir WBCN total dose average latter patients decrease mean WBCN variability WBCN clearance mL/min body surface area Partial responses patient hepatoma non-Hodgkin lymphoma dosing means dose intensity incidence life-threatening toxicity due decrease variability target WBC 